2017 – Page 31 – Policy & Medicine

New York Governor Unveils Plan to “Curb” Drug Pricing

ABIM Increases Physician Choice with New Assessment Option

Product Price Hikes – When Business and Compliance Collide

Connecticut APRN Reporting Policy Starting to Come to Fruition…Kind Of

Drug Wholesalers to Pay $36 Million Over West Virginia Pill Mill Claims

Avoiding the Patient Assistance Program Spotlight

FDA Finalizes Guidance on Assigning Non-Proprietary Names to Biologics and Biosimilars

CMS Missing Critical QPP Infrastructure

2017 Biosimilar Update

FDA Announces Safety Labeling Changes Program